Oppenheimer Initiates Coverage of CorMedix at Outperform
Published . Updated .
Fintel reports that on September 23, 2026, Oppenheimer initiated coverage of CorMedix (NASDAQGM:CRMD) (DB:19KA) with a Outperform recommendation.CorMedix Inc., headquartered in the United States, is a biopharmaceutical company mainly focused on developing and commercializing ther
Directly affected
- CRMD CorMedix
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Fintel reports that on September 23, 2026, Oppenheimer initiated coverage of CorMedix (NASDAQGM:CRMD) (DB:19KA) with a Outperform recommendation.CorMedix Inc., headquartered in the United States, is a biopharmaceutical company mainly focus…
Source: Nasdaq Markets
CorMedix (CRMD) since “Oppenheimer Initiates Coverage of CorMedix at Outperform,” compared with the market
Since the first closing price after “Oppenheimer Initiates Coverage of CorMedix at Outperform,” CorMedix (CRMD) is -4.96%. The S&P 500 fund (SPY) is -0.09% over the same days, a -4.87% difference versus the market.
Who is named in “Oppenheimer Initiates Coverage of CorMedix at Outperform”
Companies carried with this story
- CRMD CorMedix
CorMedix (CRMD) is linked, with no stored direction, high confidence in the 23 Sep 2026 story “Oppenheimer Initiates Coverage of CorMedix at Outperform.” Reason on file: The reported development directly names CORMEDIX INC in the headline; GA resolved that company to CRMD
How “Oppenheimer Initiates Coverage of CorMedix at Outperform” reaches CorMedix (CRMD)
“Oppenheimer Initiates Coverage of CorMedix at Outperform” (23 Sep 2026) reaches CorMedix (CRMD) through this story.
What ties CorMedix (CRMD) to the headline is this: The reported development directly names CORMEDIX INC in the headline; GA resolved that company to CRMD
Dates in the story, and the CorMedix (CRMD) price range
CRMD traded between 7.05 and 8.18 across 20 sessions. The latest close on file is 7.38.
How solid “Oppenheimer Initiates Coverage of CorMedix at Outperform” looks
14 out of 100
“Oppenheimer Initiates Coverage of CorMedix at Outperform” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.